Strosberg, Jonathan
Cives, Mauro https://orcid.org/0000-0002-3013-1816
Article History
First Online: 9 July 2024
Competing interests
: J.S. has acted as a consultant of Exelixis, Harpoon Therapeutics and Novartis and has received research funding from ITM, Novartis, Radiomedix and RayzeBio. M.C. has acted as a consultant of AAA, Advanz, Esteve, Harbour Biomedical, Harpoon Therapeutics and Novartis, and has received research funding from Advanz.